June 2015
Volume 56, Issue 7
Free
ARVO Annual Meeting Abstract  |   June 2015
Vancomycin incorporated collagen hydrogel implant for the prevention of ocular infections
Author Affiliations & Notes
  • DEBASISH MONDAL
    Tissue Engineering and Stem Cell Group, Singapore Eye Research Institute, Singapore, Singapore
  • Andri K Riau
    Tissue Engineering and Stem Cell Group, Singapore Eye Research Institute, Singapore, Singapore
    School of Materials Science and Engineering, Nanyang Technological University, Singapore, Singapore
  • Elavazhagan Murugan
    Tissue Engineering and Stem Cell Group, Singapore Eye Research Institute, Singapore, Singapore
  • Thet Tun Aung
    Anti-Infectives Research Group, Singapore Eye Research Institute, Singapore, Singapore
  • Bo Liedberg
    School of Materials Science and Engineering, Nanyang Technological University, Singapore, Singapore
    Interdisciplinary Graduate School, Nanyang Technological University, Singapore, Singapore
  • Subbu S Venkatraman
    School of Materials Science and Engineering, Nanyang Technological University, Singapore, Singapore
  • Jodhbir S Mehta
    Tissue Engineering and Stem Cell Group, Singapore Eye Research Institute, Singapore, Singapore
    Cornea and External Eye Disease, Singapore National Eye Center, Singapore, Singapore
  • Footnotes
    Commercial Relationships DEBASISH MONDAL, None; Andri Riau, None; Elavazhagan Murugan, None; Thet Tun Aung, None; Bo Liedberg, None; Subbu Venkatraman, None; Jodhbir Mehta, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2015, Vol.56, 4135. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      DEBASISH MONDAL, Andri K Riau, Elavazhagan Murugan, Thet Tun Aung, Bo Liedberg, Subbu S Venkatraman, Jodhbir S Mehta; Vancomycin incorporated collagen hydrogel implant for the prevention of ocular infections . Invest. Ophthalmol. Vis. Sci. 2015;56(7 ):4135.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: To develop a sustained delivery system to improve the release kinetics of vancomycin as well as its therapeutic effectiveness to prevent postoperative corneal infection.

Methods: Vancomycin was incorporated into an engineered collagen hydrogel (10 and 15 wt%) scaffold through N-ethyl-N'-[3-dimethylaminopropyl] carbodiimide/N-hydroxy succinimide (EDC/NHS) crosslinking technique. Vancomycin incorporation into the collagen hydrogel was examined by fourier transform infrared spectroscopy (FTIR) and quantified spectrophotometrically after collagen digestion with collagenase. Mechanical stability of hydrogel was measured by Instron instrument. In vitro release profile of vancomycin was measured in PBS at 37°C. Structural integrity of released vancomycin was assessed by circular dichroism (CD) spectroscopy. The minimum inhibitory concentration (MIC) of control and released vancomycin against S.aureus (SA) was determined by inoculating with bacterial suspension (106 colony-forming unit/ml). The wells were examined spectrophotometrically for visible bacterial growth as evidenced by turbidity after 24h incubation at 37°C.

Results: FTIR spectrum showed the incorporation of vancomycin in the collagen hydrogel as evidenced by presence of characteristic peaks of vancomycin (3075 cm-1, 1640 cm-1, and 1545 cm-1and 1423 cm-1, the bands were attributed to phenolic O-H, C=O stretching, C=C and C-C mode of vibration, respectively). Mechanical test result showed 15% collagen hydrogel yielded significantly higher tensile strength compared to the 10% hydrogel (0.317 ± 0.021 and 0.259 ± 0.007 MPa for 15% and 10% respectively, p=0.03). The addition of vancomycin in the hydrogel slightly reduced the tensile strength and Young’s modulus, but the difference was not significant (p=0.3). Vancomycin release pattern and amount was same for the different percentage (10% and 15%) hydrogel (p>0.05). The release was in a sustained manner for 7 days period with concentrations above the theoretical MIC of vancomycin against SA (2 µg/ml). Antimicrobial assay showed that the MIC of released vancomycin up to day 5 was the same as control (1 µg/ml), but MIC on day 7 was increased to 4 µg/ml. CD result revealed significant perturbation of vancomycin structure on day 7.

Conclusions: Our study suggests that collagen hydrogel implant can be used as a delivery system of vancomycin for 7 days above MIC, to prevent the postoperative ocular infection.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×